US20090149864A1 - Complex vaso-occlusive coils - Google Patents

Complex vaso-occlusive coils Download PDF

Info

Publication number
US20090149864A1
US20090149864A1 US12/353,177 US35317709A US2009149864A1 US 20090149864 A1 US20090149864 A1 US 20090149864A1 US 35317709 A US35317709 A US 35317709A US 2009149864 A1 US2009149864 A1 US 2009149864A1
Authority
US
United States
Prior art keywords
vaso
loop
loops
plane
coil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/353,177
Inventor
Stephen Christopher Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker European Operations Holdings LLC
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US12/353,177 priority Critical patent/US20090149864A1/en
Publication of US20090149864A1 publication Critical patent/US20090149864A1/en
Assigned to STRYKER CORPORATION, STRYKER NV OPERATIONS LIMITED reassignment STRYKER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER MEDTECH LIMITED
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Assignors: STRYKER MEDTECH LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS III, LLC reassignment STRYKER EUROPEAN HOLDINGS III, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS I, LLC
Assigned to STRYKER EUROPEAN OPERATIONS HOLDINGS LLC reassignment STRYKER EUROPEAN OPERATIONS HOLDINGS LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS III, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device

Definitions

  • the present invention relates generally to vaso-occlusive devices, and more particularly, to vaso-occlusive coils having out-of-plane helical elements.
  • Vaso-occlusive devices are surgical implants that are placed within an opening in the vasculature which is to be occluded, such as, for example, within an aneurismal cavity to form an embolus by blocking the flow of blood.
  • Vaso-occlusive devices are typically delivered and placed at a selected site in the vasculature using a catheter in a minimally invasive procedure.
  • numerous coils are implanted in the site, e.g., an aneurysm, until an adequate density has been achieved.
  • Vaso-occlusive coils are usually constructed of a wire made of a metal or metal alloy wound into a helix. Such vaso-occlusive coils are typically manufactured to assume a certain shape upon discharge of the device from a distal end of a catheter into a treatment site. The shape of these coil is defined by the shape of the coil in a “free energy state,” that is a state where there are no outside forces acting on the coil.
  • a variety of such vaso-occlusive coils are known. For instance, U.S. Pat. No. 4,994,069, issued to Ritchart et al., describes a vaso-occlusive coil that assumes a linear helical configuration when stretched and a folded, convoluted configuration when released from the catheter.
  • the stretched condition is used in placing the coil at the desired site via passage through the catheter.
  • the coil assumes a relaxed configuration—which is better suited to occlude the vessel—once the device is released from the catheter.
  • Ritchart et al. describes a variety of secondary shapes including “flower” shapes and double vortices. Unlike vaso-occlusive coils used prior to that time, Ritchart et al. discloses using a coil that is relatively soft and is delivered to the site using a pusher within a catheter lumen. Upon discharge from the delivery catheter, the coil may undertake a number of random or pre-determined configurations useful to fill the site.
  • vaso-occlusive coils may be used for filling relatively small vessel sites, e.g., 0.5-6.0 mm in diameter.
  • the coils themselves are described as being between 0.254 and 0.762 mm in diameter.
  • the length of the wire making up the vaso-occlusive coil is typically 15 to 40 times the diameter of the vessel to be occluded.
  • the wire used to make up the coils may be, for instance, 0.051 to 0.152 mm in diameter. Tungsten, platinum, and gold threads or wires are typically preferred.
  • Such coils may be easily imaged radiographically, readily located at a well defined vessel site, and retrieved, if necessary.
  • the coils In order for vaso-occlusive coils to be most effective, it is desirable for the coils to fill a peripheral shell of the aneurysm. Ideally, the coils fill the void in a complex, but semi-uniform manner. However, because numerous coils are implanted, it is desirable that the coils do not become overly intertwined or otherwise prevent additional coils from being inserted.
  • a vaso-occlusive device comprises a member that forms a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series.
  • Each plane forms an angle greater than 30 degrees with any immediately proceeding and any immediately succeeding plane.
  • each plane may form an angle between 45 and 90 degrees with any immediately proceeding and any immediately succeeding plane.
  • each plane may be perpendicular to any immediately proceeding and any immediately succeeding plane.
  • the loops may be helical, elliptical, oval, or some other shape or combination of shapes.
  • a pair of successive loops of the series may be connected by a linear member.
  • a distal most loop of the series having a diameter smaller than a diameter of an immediately preceding loop.
  • FIG. 1 shows the geometry of an exemplary member for use in forming a vaso-occlusive coil.
  • FIG. 2 is a side view of an exemplary helical occlusive coil in a free energy state configuration.
  • FIG. 3A is a side view of an exemplary helical occlusive coil in a deployed confined state.
  • FIG. 3B illustrates an exemplary deployed vaso-occlusive coil in a nearly uniformly distributed shell configuration.
  • FIG. 4 is a perspective view of a coil in a free energy state in accordance with one embodiment of the invention.
  • FIG. 5 is a perspective view of a mandrel suitable for winding a coil, according to embodiments of the invention.
  • FIG. 6 is a perspective view of a mandrel, wound with a member, for use in forming a coil according to one embodiment of the invention.
  • FIG. 7 is a perspective view of a mandrel, wound with a member, for use in forming a coil according to another embodiment of the invention.
  • FIG. 8 is a side view of the coil of FIG. 4 in a deployed confined state.
  • a vaso occlusive coil is a “coil of a coil.”
  • the “primary configuration” refers to the member obtained when a wire is shaped into a coil, for example, as a member to be used to form an occlusive device.
  • the “secondary configuration” refers to the structure obtained when the member in the primary configuration is further shaped, e.g., by winding around a mandrel.
  • the “free energy state” refers to the theoretical three-dimensional configuration assumed by the member as it would exist with no outside forces on it in its secondary configuration.
  • the “deployed configuration” refers to the shape after the coil has been deployed from the catheter.
  • the deployed configuration of a particular device may differ, depending on whether the device is deployed into the open, or whether it is deployed into a body cavity which may influence the three-dimensional structures.
  • the deployed configurations generally comprise overlapping and intertwining loops or ovals of the strand of the secondary configuration.
  • the loops or ovals can form a closed structure such as an “O” shape (e.g., circle, oval, etc.) or can be open such as a “C” or “U” shape.
  • FIG. 1 illustrates a member 100 for forming a vaso-occlusive coil.
  • the member 100 comprises a length of wire 102 formed into the primary configuration of a helical microcoil.
  • the wire 102 may be any material suitable for forming a vaso-occlusive device including platinum, rhodium, palladium, tungsten, gold, silver, nitinol, and various alloys of these materials.
  • the coil is made from platinum or a platinum-tungsten alloy.
  • the member 100 is comprised of a series of helices 104 ( a ), 104 ( b ), 104 ( c ), 104 ( d ), 104 ( e ) each having a diameter that is typically 0.125 mm to 0.625 mm.
  • the member 100 is formed by winding the wire 102 under tension onto a cylindrical mandrel. Once formed, the length of the member 100 may range from 5 mm to 1000 mm depending on the application.
  • the amount of tension applied when forming the wire 102 , the diameter of the wire 102 , the diameter of the helices, and the spacing between the helices, are all variables which determine the stiffness of the member 100 .
  • the member 100 may also be constructed such that any of the aforementioned variables will vary along the length of the member.
  • FIG. 2 illustrates a conventional helical vaso-occlusive coil 200 shown in a free energy state.
  • the coil 200 is formed from a member, such as that depicted in FIG. 1 .
  • the coil 200 is a helical wound coil having a series of loops 202 ( a ), 202 ( b ), 202 ( c ), 202 ( d ), 202 ( e ). Therefore, in this coil, the secondary configuration is geometrically shaped similar to the member from which it is formed.
  • the loops 202 ( a ), 202 ( b ), 202 ( c ), 202 ( d ), 202 ( e ) may be the same size and shape (as shown) or may vary in size and shape (not shown).
  • the loops 202 ( a ), 202 ( b ), 202 ( c ), 202 ( d ), 202 ( e ) are helices each having a diameter that is typically 2 mm to 20 mm.
  • the number of loops 202 ( a ), 202 ( b ), 202 ( c ) 202 ( d ), 202 ( e ) may vary depending on the desired length of the coil.
  • the length of a conventional helical vaso-occlusive coil typically ranges from 2 cm-80 cm, depending on the application for which it will be used.
  • FIG. 3A illustrates a deployed vaso-occlusive coil 300 , such as that depicted in FIG. 2 .
  • the coil 300 is shown in a constrained deployed configuration, meaning it is constrained by a body cavity (not shown) into which it is deployed.
  • the deployed coil 300 remains helical in nature and has an axial length.
  • Such conventional helical coils fail to uniformly fill the peripheral shell “outer sphere” of the aneurysm. Instead coils having this type of structure tend to maintain some degree of axial symmetry when deployed.
  • FIG. 3B illustrates a deployed vaso-occlusive coil 310 in a nearly uniformly distributed shell configuration. Successively placed coils would then assume the shape of ever-decreasing diameter shells until the aneurysm is substantially filled. Packing of coils in this manner maximizes the filling density and increases the long-term stability of the mass of coils.
  • FIG. 4 depicts a vaso-occlusive coil 400 in a free energy state according to an embodiment of the invention.
  • this coil 400 is described as a complex out-of-plane helical coil.
  • the vaso-occlusive coil 400 is formed from a member, such as that depicted in FIG. 1 .
  • the vaso-occlusive coil 400 is a series of loops 402 ( a ), 402 ( b ), 402 ( c ), 402 ( d ).
  • Each loop 402 ( a - d ) lies along a different axis 404 ( a ), 404 ( b ), 404 ( c ), and 404 ( d ), respectively, and in a separate plane from any other loop 402 of the series.
  • coil 400 is formed from a series of loops, where the series has at least four successive loops 402 , each having different axis and lying in a separate plane from any other loop 402 in the series, as described above.
  • Adjacent planes, in which the loops lie form an angle of at least 30 degrees and not more that 90 degrees.
  • adjacent planes form an angle of between 45 and 90 degrees and more preferably, each plane is perpendicular to an immediately preceding, or immediately succeeding plane.
  • the coil may be formed from multiple series of loops, depending on the desired overall length of the coil and the application for which it is used.
  • a primary member such as that shown in FIG. 1
  • the member is formed into the secondary configuration by heat treatment, which is well known in the art.
  • the member may be initially formed into the secondary configuration by winding or wrapping the member around a suitably sized and shaped mandrel of a refractory material and then subjecting the member to heat treatment for a specific period of time.
  • the resulting secondary configuration is, therefore, made permanent in a free energy state.
  • FIG. 5 shows a mandrel 500 for use in the manufacture of a vaso-occlusive coil, such as that depicted in FIG. 4 .
  • the mandrel is made of a refractory material and includes a series of posts 502 ( a - i ) around which a member having a primary configuration may be wound. At least four of the posts 502 ( a - d ) each have a unique central axis 504 ( a - d ).
  • the posts 502 ( a - d ) are arranged such that the central axis of adjacent posts, e.g., 502 ( a ) and 502 ( b ), are at an angle greater than 30 degrees and not more than 90 degrees, and preferably between 45 degrees and 90 degrees. As shown in FIG. 5 , the posts 502 ( a - d ) intersect such that the central axes of any two adjacent posts, e.g., 502 ( a ) and 502 ( b ), are perpendicular to one another.
  • the mandrel 500 is constructed so that a member, such as that depicted in FIG. 1 , may be wound in either a clockwise or counterclockwise direction to create the loops. Further, the loops may be created by winding each loop in the same direction, in alternating directions, or in a random selection of directions.
  • each loop 402 ( a - d ) is shown as having a helical form. It will be apparent that, in addition to a helical form, each loop may be formed in an alternate form, such as elliptical or oval. While FIG. 4 shows all loops 402 ( a - d ) having a similar form, any or each loop 402 ( a - d ) could take on a different form such that the series could be any combination of forms such as helical, oval or elliptical.
  • the size and shape of the loops 402 ( a - d ) is dictated by the size and shape of the periphery of the posts of the mandrel on which a member is wound to create the coil. Therefore, the mandrel posts could be sized and shaped to accommodate any desired combination.
  • the helical form of the loops 402 ( a - d ) is created by rotating the member about the axis 504 ( a - d ) of the post 502 ( a - d ) on the mandrel 500 .
  • Each loop 402 ( a - d ) is constructed by making at least 0.5 rotations and not more than 3.5 rotations about the axis 504 ( a - d ) of the post 502 ( a - d ) on the mandrel 500 .
  • each loop 402 ( a - e ) is depicted as having roughly the same size, it may be desirable to have a distal most loop 402 ( e ) smaller than an immediately successive loop 402 ( d ).
  • a distal loop of a coil is defined as the loop located at a distal end 408 , which is the end of the coil 400 which enters the aneurysm first while a proximal end 406 of the coil 400 is that end which is releasably attached to a push wire or other mechanism for moving the coil through a catheter and to a treatment site.
  • the loops 402 ( a - e ) are helices each has a diameter that is typically 2 mm-20 mm. Loops of varying forms are similarly sized.
  • the length of the coil 400 may vary depending on the application, preferably the length ranges from 2 cm-80 cm.
  • the vaso-occlusive coil as shown in FIG. 4 is a series of loops directly connected, such that the end of one loop, i.e. 402 ( a ), is immediately connected to the start of the next loop, i.e. 402 ( b ). That is, there is no distinction between where one loop 402 ( a ) ends and the next loop 402 ( b ) begins.
  • a coil formed in this way thereby eliminates any linear sections in the secondary configuration.
  • it is desirable to separate loops and a member may be wound on a mandrel such that the loops are connected by a curvilinear or linear portion of the member created during the winding process.
  • a mandrel 600 is wound with a member, such as that shown in FIG. 1 , to create a linear connection of successive loops.
  • the member is wound creating a loop 604 around a post 602 .
  • a length 608 of the member is laid axial along the post 606 .
  • This length 608 connects the loop 604 created by the winding the member on post 602 to the loop 610 created by successive winding on the adjacent post 612 .
  • the loops 604 and 610 are connected by a linear segment represented by the length 608 of the portion the member which is laid axially along the post 606 .
  • FIG. 7 depicts a mandrel 700 wound with a member, such as that shown in FIG. 1 , to create a curvilinear connection of successive loops.
  • a member is wound around a post 702 creating a loop 704 .
  • a length of the member 708 is wrapped around the post 706 .
  • the length 708 is wrapped such that it extends axially along as well as partially around the periphery of the post 706 .
  • This length 708 connects the loop 704 created by the winding the member on post 702 to a loop 712 created by successive winding on the adjacent post 710 .
  • the loops 704 , 712 are connected by a curvilinear segment.
  • a proximal end 406 of the vaso-occlusive coil is attached to a distal end of a guidewire or microcatheter (not shown).
  • the vaso-occlusive coil may be attached and subsequently detached in any known manner, such as by physical pushing, or by electrolytic or mechanical detachment.
  • a target site is visualized by conventional means known in the art.
  • the target site is an aneurysm 802 .
  • the aneurysm is defined by a dome 804 coming off a branch of an artery 806 .
  • a catheter 808 is inserted in the artery 806 , by means known in the art, until it reaches the dome 804 .
  • a vaso-occlusive coil 810 passes through the catheter by means of a guidewire or microcatheter until the vaso-occlusive coil enters the dome 804 of the aneurysm 802 .
  • the end loop (not shown) at the distal end of the vaso-occlusive coil enters the aneurysm 802 first.
  • the remaining loops are then advanced into and fill the aneurysm 802 .
  • the diameter of the majority of the loops are approximately the same size as the dome 804 , however the entire vaso-occlusive coil is larger than the dome 804 itself and therefore the coil takes on a semi-constrained deployed configuration 810 as it fills the aneurysm 802 .
  • the vaso-occlusive coil of the invention is a desirable shape for it tends to fill the interior area 812 of the dome 804 while also filling the peripheral shell of the aneurysm 802 .
  • the deployed coil takes on a more complex, but semi-uniform shape as compared with conventional helical coils.
  • the constrained deployed configuration of the coil is a higher energy state than the unconstrained deployed configuration since the aneurysm 802 constrains the coil. Nonetheless, since the diameter of the loops are approximately the same size as the aneurysm dome, the amount of force required to constrain the coil within the aneurysm dome is kept to a minimum. Once placed, the coil tends to remain in place, constrained by the walls 814 of the dome 804 , and further compaction of the coil is minimized. Additional coils may be inserted into the aneurysm until the desired density of coils in the aneurysm is achieved.

Abstract

A vaso-occlusive device includes a member that forms a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series. Each plane in which a loop lies forms an angle greater than 30 degrees with any immediately proceeding, and any immediately succeeding, plane.

Description

    RELATED APPLICATION DATA
  • This application is a continuation application of co-pending U.S. patent application Ser. No. 10/790,982 filed Mar. 1, 2004, the priority of which is claimed under 35 U.S.C. §120, and the contents of which are incorporated herein by reference as though set forth in full.
  • FIELD OF THE INVENTION
  • The present invention relates generally to vaso-occlusive devices, and more particularly, to vaso-occlusive coils having out-of-plane helical elements.
  • BACKGROUND OF THE INVENTION
  • Vaso-occlusive devices are surgical implants that are placed within an opening in the vasculature which is to be occluded, such as, for example, within an aneurismal cavity to form an embolus by blocking the flow of blood. Vaso-occlusive devices are typically delivered and placed at a selected site in the vasculature using a catheter in a minimally invasive procedure. In order to create an embolus, numerous coils are implanted in the site, e.g., an aneurysm, until an adequate density has been achieved.
  • Vaso-occlusive coils are usually constructed of a wire made of a metal or metal alloy wound into a helix. Such vaso-occlusive coils are typically manufactured to assume a certain shape upon discharge of the device from a distal end of a catheter into a treatment site. The shape of these coil is defined by the shape of the coil in a “free energy state,” that is a state where there are no outside forces acting on the coil. A variety of such vaso-occlusive coils are known. For instance, U.S. Pat. No. 4,994,069, issued to Ritchart et al., describes a vaso-occlusive coil that assumes a linear helical configuration when stretched and a folded, convoluted configuration when released from the catheter. The stretched condition is used in placing the coil at the desired site via passage through the catheter. The coil assumes a relaxed configuration—which is better suited to occlude the vessel—once the device is released from the catheter. Ritchart et al., describes a variety of secondary shapes including “flower” shapes and double vortices. Unlike vaso-occlusive coils used prior to that time, Ritchart et al. discloses using a coil that is relatively soft and is delivered to the site using a pusher within a catheter lumen. Upon discharge from the delivery catheter, the coil may undertake a number of random or pre-determined configurations useful to fill the site.
  • Known vaso-occlusive coils may be used for filling relatively small vessel sites, e.g., 0.5-6.0 mm in diameter. The coils themselves are described as being between 0.254 and 0.762 mm in diameter. The length of the wire making up the vaso-occlusive coil is typically 15 to 40 times the diameter of the vessel to be occluded. The wire used to make up the coils may be, for instance, 0.051 to 0.152 mm in diameter. Tungsten, platinum, and gold threads or wires are typically preferred. Such coils may be easily imaged radiographically, readily located at a well defined vessel site, and retrieved, if necessary.
  • In order for vaso-occlusive coils to be most effective, it is desirable for the coils to fill a peripheral shell of the aneurysm. Ideally, the coils fill the void in a complex, but semi-uniform manner. However, because numerous coils are implanted, it is desirable that the coils do not become overly intertwined or otherwise prevent additional coils from being inserted.
  • SUMMARY OF THE INVENTION
  • In one embodiment of the invention, a vaso-occlusive device comprises a member that forms a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series. Each plane forms an angle greater than 30 degrees with any immediately proceeding and any immediately succeeding plane. By way of non-limiting example, each plane may form an angle between 45 and 90 degrees with any immediately proceeding and any immediately succeeding plane. By way of another, non-limiting example, each plane may be perpendicular to any immediately proceeding and any immediately succeeding plane.
  • The loops may be helical, elliptical, oval, or some other shape or combination of shapes. A pair of successive loops of the series may be connected by a linear member. In one embodiment, a distal most loop of the series having a diameter smaller than a diameter of an immediately preceding loop.
  • Other aspects and features of the invention will be evident from reading the following detailed description of the illustrated embodiments, which are intended to illustrate, not limit, the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The drawings illustrate the design and utility of embodiments of the invention, in which similar elements are referred to by common reference numerals, and in which:
  • FIG. 1 shows the geometry of an exemplary member for use in forming a vaso-occlusive coil.
  • FIG. 2 is a side view of an exemplary helical occlusive coil in a free energy state configuration.
  • FIG. 3A is a side view of an exemplary helical occlusive coil in a deployed confined state.
  • FIG. 3B illustrates an exemplary deployed vaso-occlusive coil in a nearly uniformly distributed shell configuration.
  • FIG. 4 is a perspective view of a coil in a free energy state in accordance with one embodiment of the invention.
  • FIG. 5 is a perspective view of a mandrel suitable for winding a coil, according to embodiments of the invention.
  • FIG. 6 is a perspective view of a mandrel, wound with a member, for use in forming a coil according to one embodiment of the invention.
  • FIG. 7 is a perspective view of a mandrel, wound with a member, for use in forming a coil according to another embodiment of the invention.
  • FIG. 8 is a side view of the coil of FIG. 4 in a deployed confined state.
  • DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
  • Various embodiments of the invention are described hereinafter with reference to the figures. It should be noted that the figures are not drawn to scale, and are intended only to facilitate the description of specific embodiments of the invention, not as an exhaustive description. Various aspects, features, and advantages described in conjunction with a particular illustrated embodiment are not necessarily limited to that embodiment, but may be practiced with other embodiments, even if not so illustrated or specifically described herein.
  • The complex coil designs of the invention are particularly useful in treating aneurysms. The shape provided herein results in an improved blood flow baffle design for the outer sphere of the aneurysm. The complex out-of-plane helical coil design is easily packed into an aneurysm and the structure of the coil reduces the incidence of coil compaction, and of coils getting caught on one another preventing the insertion of additional coils. Generally, a vaso occlusive coil is a “coil of a coil.” In other words, as used herein, the “primary configuration” refers to the member obtained when a wire is shaped into a coil, for example, as a member to be used to form an occlusive device. The “secondary configuration” refers to the structure obtained when the member in the primary configuration is further shaped, e.g., by winding around a mandrel.
  • The “free energy state” refers to the theoretical three-dimensional configuration assumed by the member as it would exist with no outside forces on it in its secondary configuration. The “deployed configuration” refers to the shape after the coil has been deployed from the catheter. The deployed configuration of a particular device may differ, depending on whether the device is deployed into the open, or whether it is deployed into a body cavity which may influence the three-dimensional structures. The deployed configurations generally comprise overlapping and intertwining loops or ovals of the strand of the secondary configuration. The loops or ovals can form a closed structure such as an “O” shape (e.g., circle, oval, etc.) or can be open such as a “C” or “U” shape.
  • FIG. 1 illustrates a member 100 for forming a vaso-occlusive coil. The member 100 comprises a length of wire 102 formed into the primary configuration of a helical microcoil. The wire 102 may be any material suitable for forming a vaso-occlusive device including platinum, rhodium, palladium, tungsten, gold, silver, nitinol, and various alloys of these materials. Preferably, the coil is made from platinum or a platinum-tungsten alloy.
  • The member 100 is comprised of a series of helices 104(a), 104(b), 104(c), 104(d), 104(e) each having a diameter that is typically 0.125 mm to 0.625 mm. The member 100 is formed by winding the wire 102 under tension onto a cylindrical mandrel. Once formed, the length of the member 100 may range from 5 mm to 1000 mm depending on the application. The amount of tension applied when forming the wire 102, the diameter of the wire 102, the diameter of the helices, and the spacing between the helices, are all variables which determine the stiffness of the member 100. The member 100 may also be constructed such that any of the aforementioned variables will vary along the length of the member.
  • FIG. 2 illustrates a conventional helical vaso-occlusive coil 200 shown in a free energy state. The coil 200 is formed from a member, such as that depicted in FIG. 1. The coil 200 is a helical wound coil having a series of loops 202(a), 202(b), 202(c), 202(d), 202(e). Therefore, in this coil, the secondary configuration is geometrically shaped similar to the member from which it is formed. The loops 202(a), 202(b), 202(c), 202(d), 202 (e) may be the same size and shape (as shown) or may vary in size and shape (not shown). Generally the loops 202(a), 202(b), 202(c), 202(d), 202 (e) are helices each having a diameter that is typically 2 mm to 20 mm. The number of loops 202(a), 202(b), 202(c) 202(d), 202(e) may vary depending on the desired length of the coil. The length of a conventional helical vaso-occlusive coil typically ranges from 2 cm-80 cm, depending on the application for which it will be used.
  • A deployed coil formed in a helical secondary shape enters a treatment site, such as an aneurysm, in a helical shaped fashion. FIG. 3A illustrates a deployed vaso-occlusive coil 300, such as that depicted in FIG. 2. The coil 300 is shown in a constrained deployed configuration, meaning it is constrained by a body cavity (not shown) into which it is deployed. The deployed coil 300 remains helical in nature and has an axial length. Such conventional helical coils fail to uniformly fill the peripheral shell “outer sphere” of the aneurysm. Instead coils having this type of structure tend to maintain some degree of axial symmetry when deployed. Subsequently placed coils adopt a similar geometry but not necessarily with the same axial symmetry. This manner of filling leads to non-uniform packing with open void spaces. Poorly packed coil masses are susceptible to rearrangement of the individual coils due to the relatively large amount of free space remaining in the aneurysm. Rearrangements in the architecture of the coil mass may lead to an unfavorable mechanical state which in turn may lead to future recanalization or regrowth of the aneurysm.
  • A more desirable situation is to create a coil which expands to fill the inner periphery of an aneurysm in a manner that resembles a uniformly distributed ovoid or spherical shell. FIG. 3B illustrates a deployed vaso-occlusive coil 310 in a nearly uniformly distributed shell configuration. Successively placed coils would then assume the shape of ever-decreasing diameter shells until the aneurysm is substantially filled. Packing of coils in this manner maximizes the filling density and increases the long-term stability of the mass of coils.
  • FIG. 4 depicts a vaso-occlusive coil 400 in a free energy state according to an embodiment of the invention. Generally, this coil 400 is described as a complex out-of-plane helical coil. The vaso-occlusive coil 400 is formed from a member, such as that depicted in FIG. 1. The vaso-occlusive coil 400 is a series of loops 402(a), 402(b), 402(c), 402(d). Each loop 402 (a-d) lies along a different axis 404(a), 404(b), 404(c), and 404(d), respectively, and in a separate plane from any other loop 402 of the series.
  • In the illustrated embodiment, coil 400 is formed from a series of loops, where the series has at least four successive loops 402, each having different axis and lying in a separate plane from any other loop 402 in the series, as described above. Adjacent planes, in which the loops lie, form an angle of at least 30 degrees and not more that 90 degrees. Preferably, adjacent planes form an angle of between 45 and 90 degrees and more preferably, each plane is perpendicular to an immediately preceding, or immediately succeeding plane. The coil may be formed from multiple series of loops, depending on the desired overall length of the coil and the application for which it is used.
  • To create coil 400, a primary member, such as that shown in FIG. 1, is formed into the secondary configuration by heat treatment, which is well known in the art. For example, the member may be initially formed into the secondary configuration by winding or wrapping the member around a suitably sized and shaped mandrel of a refractory material and then subjecting the member to heat treatment for a specific period of time. The resulting secondary configuration is, therefore, made permanent in a free energy state.
  • FIG. 5 shows a mandrel 500 for use in the manufacture of a vaso-occlusive coil, such as that depicted in FIG. 4. The mandrel is made of a refractory material and includes a series of posts 502 (a-i) around which a member having a primary configuration may be wound. At least four of the posts 502(a-d) each have a unique central axis 504 (a-d). The posts 502(a-d) are arranged such that the central axis of adjacent posts, e.g., 502(a) and 502(b), are at an angle greater than 30 degrees and not more than 90 degrees, and preferably between 45 degrees and 90 degrees. As shown in FIG. 5, the posts 502(a-d) intersect such that the central axes of any two adjacent posts, e.g., 502(a) and 502(b), are perpendicular to one another. The mandrel 500 is constructed so that a member, such as that depicted in FIG. 1, may be wound in either a clockwise or counterclockwise direction to create the loops. Further, the loops may be created by winding each loop in the same direction, in alternating directions, or in a random selection of directions.
  • Returning to FIG. 4, each loop 402(a-d) is shown as having a helical form. It will be apparent that, in addition to a helical form, each loop may be formed in an alternate form, such as elliptical or oval. While FIG. 4 shows all loops 402 (a-d) having a similar form, any or each loop 402 (a-d) could take on a different form such that the series could be any combination of forms such as helical, oval or elliptical. The size and shape of the loops 402 (a-d) is dictated by the size and shape of the periphery of the posts of the mandrel on which a member is wound to create the coil. Therefore, the mandrel posts could be sized and shaped to accommodate any desired combination.
  • The helical form of the loops 402 (a-d) is created by rotating the member about the axis 504 (a-d) of the post 502 (a-d) on the mandrel 500. Each loop 402 (a-d) is constructed by making at least 0.5 rotations and not more than 3.5 rotations about the axis 504 (a-d) of the post 502 (a-d) on the mandrel 500. In addition, while each loop 402 (a-d) as depicted in FIG. 4 is the roughly the same size, in terms of the number of rotations, this is not a limitation of other embodiments of the invention, and the number of rotations constituting a loop may vary by individual loop. In other words, a series of loops could include loops with varying axial length.
  • While each loop 402(a-e) is depicted as having roughly the same size, it may be desirable to have a distal most loop 402(e) smaller than an immediately successive loop 402(d). A distal loop of a coil is defined as the loop located at a distal end 408, which is the end of the coil 400 which enters the aneurysm first while a proximal end 406 of the coil 400 is that end which is releasably attached to a push wire or other mechanism for moving the coil through a catheter and to a treatment site. When the loops 402 (a-e) are helices each has a diameter that is typically 2 mm-20 mm. Loops of varying forms are similarly sized. The length of the coil 400 may vary depending on the application, preferably the length ranges from 2 cm-80 cm.
  • The vaso-occlusive coil as shown in FIG. 4 is a series of loops directly connected, such that the end of one loop, i.e. 402(a), is immediately connected to the start of the next loop, i.e. 402(b). That is, there is no distinction between where one loop 402(a) ends and the next loop 402(b) begins. A coil formed in this way thereby eliminates any linear sections in the secondary configuration. However, there may be instances in which it is desirable to separate loops, and a member may be wound on a mandrel such that the loops are connected by a curvilinear or linear portion of the member created during the winding process.
  • As shown in FIG. 6, a mandrel 600, is wound with a member, such as that shown in FIG. 1, to create a linear connection of successive loops. To form such a configuration, the member is wound creating a loop 604 around a post 602. After completing the selected number of rotations of the member about the post 602 (1.25 rotations in the illustrated embodiment), a length 608 of the member is laid axial along the post 606. This length 608 connects the loop 604 created by the winding the member on post 602 to the loop 610 created by successive winding on the adjacent post 612. By constructing the coil in this way, the loops 604 and 610 are connected by a linear segment represented by the length 608 of the portion the member which is laid axially along the post 606.
  • Similarly, loops could be connected by a curvilinear segment, as illustrated in FIG. 7. FIG. 7 depicts a mandrel 700 wound with a member, such as that shown in FIG. 1, to create a curvilinear connection of successive loops. In this configuration, a member is wound around a post 702 creating a loop 704. After completing the selected number of rotations of the member about the post 702 (2.25 rotations in the illustrated embodiment), a length of the member 708 is wrapped around the post 706. The length 708 is wrapped such that it extends axially along as well as partially around the periphery of the post 706. This length 708 connects the loop 704 created by the winding the member on post 702 to a loop 712 created by successive winding on the adjacent post 710. By constructing the coil in this way, the loops 704, 712 are connected by a curvilinear segment.
  • Having described the structure of the coil, the method of using the coil is now described with reference to FIG. 8. In use, a proximal end 406 of the vaso-occlusive coil is attached to a distal end of a guidewire or microcatheter (not shown). The vaso-occlusive coil may be attached and subsequently detached in any known manner, such as by physical pushing, or by electrolytic or mechanical detachment. A target site is visualized by conventional means known in the art. For illustrative purposes, the target site is an aneurysm 802. The aneurysm is defined by a dome 804 coming off a branch of an artery 806. A catheter 808 is inserted in the artery 806, by means known in the art, until it reaches the dome 804. A vaso-occlusive coil 810, such as that shown in FIG. 4, passes through the catheter by means of a guidewire or microcatheter until the vaso-occlusive coil enters the dome 804 of the aneurysm 802.
  • The end loop (not shown) at the distal end of the vaso-occlusive coil enters the aneurysm 802 first. In some instances, it is desirable to have a smaller loop enter the aneurysm 802 first to ensure the coil remains in the dome, in such a case the end loop is smaller in diameter than the other loops. The remaining loops are then advanced into and fill the aneurysm 802. The diameter of the majority of the loops are approximately the same size as the dome 804, however the entire vaso-occlusive coil is larger than the dome 804 itself and therefore the coil takes on a semi-constrained deployed configuration 810 as it fills the aneurysm 802. The vaso-occlusive coil of the invention is a desirable shape for it tends to fill the interior area 812 of the dome 804 while also filling the peripheral shell of the aneurysm 802.
  • The deployed coil takes on a more complex, but semi-uniform shape as compared with conventional helical coils. The constrained deployed configuration of the coil is a higher energy state than the unconstrained deployed configuration since the aneurysm 802 constrains the coil. Nonetheless, since the diameter of the loops are approximately the same size as the aneurysm dome, the amount of force required to constrain the coil within the aneurysm dome is kept to a minimum. Once placed, the coil tends to remain in place, constrained by the walls 814 of the dome 804, and further compaction of the coil is minimized. Additional coils may be inserted into the aneurysm until the desired density of coils in the aneurysm is achieved.
  • As noted previously, the forgoing descriptions of the specific embodiments are presented for purposes of illustration and description, and are not intended to be exhaustive or to limit the invention to the precise forms disclosed, as many modifications and variations are possible in view of the above teachings. The embodiments were chosen and described in order to illustrate and explain principles of the invention and its practical applications, to thereby enable those skilled in the art to best utilize the invention and various embodiments thereof as suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Claims (18)

1. A vaso-occlusive device, comprising:
a member that forms a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series, including at least two non-successive loops lying in respective planes which are substantially parallel, each of the four successive loops comprising a helical form having 1.5 to 3.5 rotations about its axis, and each plane forming an angle greater than 30 degrees with any immediately preceding and any immediately succeeding plane.
2. The vaso-occlusive device of claim 1, each plane forming an angle between 45 and 90 degrees with the immediately preceding and the immediately succeeding plane.
3. The vaso-occlusive device of claim 1, each plane perpendicular to the immediately preceding and the immediately succeeding plane.
4. The vaso-occlusive device of claim 1, wherein at least one of the loops is wound in a clockwise direction, and at least one of the loops is wound in a counterclockwise direction.
5. The vaso-occlusive device of claim 1, at least one loop comprising an elliptical or oval form.
6. The vaso-occlusive device of claim 1, at least one of the loops having a different geometric form than the other loops.
7. The vaso-occlusive device of claim 1, a distal most loop of the series having a diameter smaller than a diameter of an immediately preceding loop.
8. A vaso-occlusive coil having an elongate helical primary shape, the primary shape defining a primary axis, the primary shape being wound into a secondary shape comprising:
a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series, each plane forming an angle greater than 30 degrees with any immediately preceding and any immediately succeeding plane, and at least one of the loops having a different geometric form than the other loops.
9. The vaso-occlusive device of claim 8, each plane forming an angle between 45 and 90 degrees with the immediately preceding and the immediately succeeding plane.
10. The vaso-occlusive device of claim 8, each plane perpendicular to the immediately preceding and the immediately succeeding plane.
11. The vaso-occlusive device of claim 8, wherein at least one of the loops is wound in a clockwise direction, and at least one of the loops is wound in a counterclockwise direction.
12. The vaso-occlusive device of claim 8, at least one loop comprising an elliptical or oval form.
13. The vaso-occlusive device of claim 8, a distal most loop of the series having a diameter smaller than a diameter of an immediately preceding loop.
14. A vaso-occlusive coil having an elongate helical primary shape, the primary shape defining a primary axis, the primary shape being wound into a secondary shape comprising:
a series of at least four successive loops, each loop of the series having a different axis than, and lying in a separate plane from, any other loop of the series, each plane forming an angle greater than 30 degrees with any immediately preceding and any immediately succeeding plane, wherein at least one of the loops is wound in a clockwise direction, and at least one of the loops is wound in a counterclockwise direction.
15. The vaso-occlusive device of claim 14, each plane forming an angle between 45 and 90 degrees with the immediately preceding and the immediately succeeding plane.
16. The vaso-occlusive device of claim 14, each plane perpendicular to the immediately preceding and the immediately succeeding plane.
17. The vaso-occlusive device of claim 14, at least one loop comprising an elliptical form or an oval form.
18. The vaso-occlusive device of claim 14, a distal most loop of the series having a diameter smaller than a diameter of an immediately preceding loop.
US12/353,177 2004-03-01 2009-01-13 Complex vaso-occlusive coils Abandoned US20090149864A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/353,177 US20090149864A1 (en) 2004-03-01 2009-01-13 Complex vaso-occlusive coils

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/790,982 US7485123B2 (en) 2004-03-01 2004-03-01 Complex vaso-occlusive coils
US12/353,177 US20090149864A1 (en) 2004-03-01 2009-01-13 Complex vaso-occlusive coils

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/790,982 Continuation US7485123B2 (en) 2004-03-01 2004-03-01 Complex vaso-occlusive coils

Publications (1)

Publication Number Publication Date
US20090149864A1 true US20090149864A1 (en) 2009-06-11

Family

ID=34887557

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/790,982 Active 2025-08-16 US7485123B2 (en) 2004-03-01 2004-03-01 Complex vaso-occlusive coils
US12/353,177 Abandoned US20090149864A1 (en) 2004-03-01 2009-01-13 Complex vaso-occlusive coils

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/790,982 Active 2025-08-16 US7485123B2 (en) 2004-03-01 2004-03-01 Complex vaso-occlusive coils

Country Status (5)

Country Link
US (2) US7485123B2 (en)
EP (1) EP1725174A1 (en)
JP (1) JP2007525304A (en)
CA (1) CA2556047A1 (en)
WO (1) WO2005092213A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012155100A1 (en) * 2011-05-11 2012-11-15 Microvention, Inc. Packing coil
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10869673B2 (en) 2015-02-05 2020-12-22 Boston Scientific Scimed, Inc. Embolic coil with kick-in tail

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029486B2 (en) * 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7485123B2 (en) * 2004-03-01 2009-02-03 Boston Scientific Scimed, Inc. Complex vaso-occlusive coils
EP1827251B8 (en) * 2004-11-09 2013-12-11 Stryker Corporation Vaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion
AU2006330786B2 (en) 2005-11-17 2012-02-02 Microvention, Inc. Three-dimensional complex coil
US20100076317A1 (en) * 2006-11-30 2010-03-25 Koninklijke Philips Electronics N.V. Catheter with ultrasound transducer and variable focus lens used in aneurysm assessment
US20080319527A1 (en) * 2007-06-22 2008-12-25 Lee Jeffrey A Shaped multi-durometer filler
US8968382B2 (en) 2007-12-11 2015-03-03 Cornell University Method and apparatus for restricting flow through an opening in the side wall
CN101945624A (en) * 2007-12-11 2011-01-12 康奈尔大学 Method and apparatus for sealing an opening in the side wall of a body lumen
US9089405B1 (en) * 2008-09-12 2015-07-28 Microvention, Inc. Three-dimensional complex coil
AU2010206960A1 (en) 2009-01-22 2011-08-11 Cornell University Method and apparatus for restricting flow through the wall of a lumen
EP2693981A4 (en) 2011-04-01 2015-07-01 Univ Cornell Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
WO2014002696A1 (en) * 2012-06-29 2014-01-03 株式会社カネカ Method for producing intracorporeal indwelling member
US20150297238A1 (en) * 2012-08-19 2015-10-22 Christopher G.M. Ken Geometric coil
CA2902438C (en) * 2013-03-15 2021-06-29 Fabian Hermann Urban Fuglister Tongue deformation implant
CN105899150B (en) 2013-07-31 2018-07-27 Neuvt 有限公司 Method and apparatus for Endovascular Embolization
US10010328B2 (en) 2013-07-31 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring
CN108186074A (en) 2014-02-27 2018-06-22 因库麦迪斯有限公司 For treating the framework microcoils of vascular diseases
US10709453B2 (en) 2014-05-19 2020-07-14 Kaneka Corporation In vivo indwelling member and method for producing same
KR20170036002A (en) 2014-07-25 2017-03-31 인큐메덱스, 아이엔씨. Covered embolic coils
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques
WO2017086479A1 (en) * 2015-11-19 2017-05-26 株式会社カネカ In vivo indwelling member, and in vivo indwelling member placement device provided with said in vivo indwelling member
US10842607B2 (en) 2016-10-14 2020-11-24 Microvention, Inc. Embolic coils
US11399845B2 (en) 2017-12-12 2022-08-02 Penumbra, Inc. Vascular cages and methods of making and using the same
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US11399840B2 (en) 2019-08-13 2022-08-02 Covidien Lp Implantable embolization device
US20230380842A1 (en) * 2022-05-27 2023-11-30 David A. Watson Neurocoil and mandrel for making same used in intravascular treatment

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US6322576B1 (en) * 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US6605101B1 (en) * 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) * 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7485123B2 (en) * 2004-03-01 2009-02-03 Boston Scientific Scimed, Inc. Complex vaso-occlusive coils
US7645292B2 (en) * 2003-10-27 2010-01-12 Boston Scientific Scimed, Inc. Vaso-occlusive devices with in-situ stiffening elements

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911731A (en) * 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US6638291B1 (en) 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5639277A (en) 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5826026A (en) 1995-11-09 1998-10-20 Connect-One, Ltd. Internet message communicator with direct output to a hard copy device
US6860893B2 (en) * 1997-08-29 2005-03-01 Boston Scientific Scimed, Inc. Stable coil designs
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US7033374B2 (en) 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6635069B1 (en) * 2000-10-18 2003-10-21 Scimed Life Systems, Inc. Non-overlapping spherical three-dimensional coil

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US6322576B1 (en) * 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US6605101B1 (en) * 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) * 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7645292B2 (en) * 2003-10-27 2010-01-12 Boston Scientific Scimed, Inc. Vaso-occlusive devices with in-situ stiffening elements
US7485123B2 (en) * 2004-03-01 2009-02-03 Boston Scientific Scimed, Inc. Complex vaso-occlusive coils

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
AU2012253287B2 (en) * 2011-05-11 2016-11-24 Microvention, Inc. Packing coil
US20130018409A1 (en) * 2011-05-11 2013-01-17 Microvention, Inc. Packing Coil
US10299798B2 (en) * 2011-05-11 2019-05-28 Microvention, Inc. Packing coil
WO2012155100A1 (en) * 2011-05-11 2012-11-15 Microvention, Inc. Packing coil
US10722242B2 (en) 2011-05-11 2020-07-28 Microvention, Inc. Packing coil
US11337708B2 (en) 2011-05-11 2022-05-24 Microvention, Inc. Packing coil
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US10893868B2 (en) 2012-01-20 2021-01-19 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10869673B2 (en) 2015-02-05 2020-12-22 Boston Scientific Scimed, Inc. Embolic coil with kick-in tail

Also Published As

Publication number Publication date
CA2556047A1 (en) 2005-10-06
US7485123B2 (en) 2009-02-03
US20050192618A1 (en) 2005-09-01
EP1725174A1 (en) 2006-11-29
JP2007525304A (en) 2007-09-06
WO2005092213A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
US7485123B2 (en) Complex vaso-occlusive coils
JP7195375B2 (en) Embolization device and manufacturing method thereof
US6860893B2 (en) Stable coil designs
US6322576B1 (en) Stable coil designs
EP1467663B1 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
EP1720462B1 (en) Vaso-occlusive coils with non-overlapping sections
JP2682743B2 (en) Vascular occlusion coil with thrombogenic fiber
AU2003267287A1 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
EP0743866A4 (en) Large diameter vasoocclusion coil
EP3110343B1 (en) Embolic framing microcoils
US11944313B2 (en) Implantable embolization device
EP2163212B1 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
AU2002236676A1 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
JP7423865B2 (en) Vascular occlusion device and method of manufacturing and using the same
US20230190292A1 (en) Occlusive devices with petal-shaped regions for treating vascular defects
JP2024045240A (en) Vascular occlusion device and methods of making and using same

Legal Events

Date Code Title Description
AS Assignment

Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025969/0841

Effective date: 20110103

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025969/0841

Effective date: 20110103

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034

Effective date: 20151013

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241

Effective date: 20151013

AS Assignment

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011

Effective date: 20151013

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001

Effective date: 20151013

AS Assignment

Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN

Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716

Effective date: 20190226

Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001

Effective date: 20200519